Matt Hewitt
Stock Analyst at Craig-Hallum
(0.32)
# 4,080
Out of 4,334 analysts
788
Total ratings
40.9%
Success rate
-3%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Maintained: Buy | n/a | $13.30 | - | 49 | May 21, 2026 | |
| INFU InfuSystem Holdings | Maintained: Buy | n/a | $9.66 | - | 20 | May 19, 2026 | |
| BHST BioHarvest Sciences | Maintained: Buy | n/a | $3.86 | - | 17 | May 13, 2026 | |
| MXCT MaxCyte | Reiterated: Buy | n/a | $1.04 | - | 31 | May 13, 2026 | |
| CERT Certara | Reiterated: Hold | $8 | $5.24 | +52.67% | 15 | May 12, 2026 | |
| DYAI Dyadic International | Maintained: Buy | n/a | $0.7592 | - | 10 | May 11, 2026 | |
| PARK Park Dental Partners | Maintained: Buy | n/a | $18.42 | - | 5 | May 11, 2026 | |
| APYX Apyx Medical | Reiterated: Buy | $6 | $4.13 | +45.28% | 55 | May 8, 2026 | |
| CDXS Codexis | Reiterated: Buy | $9 | $2.49 | +261.45% | 49 | May 8, 2026 | |
| BLFS BioLife Solutions | Reiterated: Buy | $32 | $23.95 | +33.61% | 32 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $4.40 | +13.64% | 31 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.65 | +164.15% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $4.94 | +82.37% | 36 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.88 | +209.28% | 19 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $23.81 | +68.00% | 30 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $204 | $115.06 | +77.30% | 55 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.00 | - | 3 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $44.41 | +23.85% | 47 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 → $330 | $229.33 | +43.90% | 66 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $15.37 | - | 51 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.47 | - | 1 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.25 | - | 1 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $97.38 | - | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.27 | - | 37 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $5.85 | +105.13% | 20 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.14 | - | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.55 | - | 12 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $16.32 | - | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.23 | n/a | 13 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $31.73 | n/a | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.58 | n/a | 2 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.45 | n/a | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $3.17 | n/a | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $15.58 | n/a | 1 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.57 | n/a | 22 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $17 | $11.92 | n/a | 2 | Oct 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $100 | $0.0002 | n/a | 1 | Jan 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $215 → $154 | $48.21 | n/a | 3 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $3.62 | n/a | 4 | Feb 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $65.49 | n/a | 1 | Nov 8, 2017 |
Schrödinger
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $13.30
Upside: -
InfuSystem Holdings
May 19, 2026
Maintained: Buy
Price Target: n/a
Current: $9.66
Upside: -
BioHarvest Sciences
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $3.86
Upside: -
MaxCyte
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.04
Upside: -
Certara
May 12, 2026
Reiterated: Hold
Price Target: $8
Current: $5.24
Upside: +52.67%
Dyadic International
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $0.7592
Upside: -
Park Dental Partners
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $18.42
Upside: -
Apyx Medical
May 8, 2026
Reiterated: Buy
Price Target: $6
Current: $4.13
Upside: +45.28%
Codexis
May 8, 2026
Reiterated: Buy
Price Target: $9
Current: $2.49
Upside: +261.45%
BioLife Solutions
May 8, 2026
Reiterated: Buy
Price Target: $32
Current: $23.95
Upside: +33.61%
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $4.40
Upside: +13.64%
May 8, 2026
Reiterated: Buy
Price Target: $7
Current: $2.65
Upside: +164.15%
May 7, 2026
Maintained: Buy
Price Target: $9
Current: $4.94
Upside: +82.37%
May 7, 2026
Reiterated: Buy
Price Target: $12
Current: $3.88
Upside: +209.28%
May 6, 2026
Reiterated: Buy
Price Target: $40
Current: $23.81
Upside: +68.00%
May 6, 2026
Reiterated: Buy
Price Target: $204
Current: $115.06
Upside: +77.30%
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $14.00
Upside: -
Apr 29, 2026
Reiterated: Buy
Price Target: $55
Current: $44.41
Upside: +23.85%
Apr 28, 2026
Maintained: Buy
Price Target: $250 → $330
Current: $229.33
Upside: +43.90%
Apr 21, 2026
Maintained: Buy
Price Target: n/a
Current: $15.37
Upside: -
Mar 25, 2026
Maintained: Buy
Price Target: n/a
Current: $1.47
Upside: -
Mar 24, 2026
Rated: Hold
Price Target: n/a
Current: $3.25
Upside: -
Feb 23, 2026
Maintained: Buy
Price Target: n/a
Current: $97.38
Upside: -
Feb 6, 2026
Maintained: Buy
Price Target: n/a
Current: $0.27
Upside: -
Dec 16, 2025
Maintained: Buy
Price Target: $12
Current: $5.85
Upside: +105.13%
Dec 9, 2025
Maintained: Buy
Price Target: n/a
Current: $5.14
Upside: -
Oct 10, 2025
Maintained: Buy
Price Target: n/a
Current: $3.55
Upside: -
Jun 17, 2025
Rated: Hold
Price Target: n/a
Current: $16.32
Upside: -
Apr 25, 2025
Maintained: Buy
Price Target: n/a
Current: $9.23
Upside: n/a
Mar 18, 2025
Maintained: Buy
Price Target: n/a
Current: $31.73
Upside: n/a
Dec 18, 2024
Rated: Buy
Price Target: n/a
Current: $1.58
Upside: n/a
Aug 7, 2024
Maintained: Buy
Price Target: n/a
Current: $3.45
Upside: n/a
Feb 9, 2024
Rated: Buy
Price Target: $6
Current: $3.17
Upside: n/a
Sep 21, 2023
Maintained: Buy
Price Target: n/a
Current: $15.58
Upside: n/a
Feb 23, 2023
Rated: Hold
Price Target: n/a
Current: $6.57
Upside: n/a
Oct 4, 2019
Reiterated: Hold
Price Target: $16 → $17
Current: $11.92
Upside: n/a
Jan 18, 2019
Maintained: Hold
Price Target: $100
Current: $0.0002
Upside: n/a
Oct 31, 2018
Downgraded: Hold
Price Target: $215 → $154
Current: $48.21
Upside: n/a
Feb 27, 2018
Maintained: Buy
Price Target: $19
Current: $3.62
Upside: n/a
Nov 8, 2017
Reiterated: Hold
Price Target: $50
Current: $65.49
Upside: n/a